Anika Therapeutics Inc.
ANIK
Market Cap$161.34M
Close$
$2.90
73.6% downside
Current Fair Value
73.6% downsideOvervalued by 73.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $161.34 Million |
|---|---|
| Enterprise Value | $133.47 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.83 |
| Beta | 0.65 |
| Outstanding Shares | 14,297,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.83 |
|---|---|
| PEG | -35.64 |
| Price to Sales | 1.57 |
| Price to Book Ratio | 1.1 |
| Enterprise Value to Revenue | 1.26 |
| Enterprise Value to EBIT | -20.1 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Anika Therapeutics Inc.
CEO: Joseph Darling